News

When a child is diagnosed with any life-threatening disease, especially cancer, the focus shifts to the child suffering from that disease—as it should. But what is often forgotten is how the entire family is affected. Understandably, we often think of primary caregivers, in most cases the parents. Very rarely do we hear a sibling’s perspective, like mine.

A pesar de su impresionante belleza montañosa, Salt Lake City viene con la compensación de un aire pobre periódico. En el informe "Salud del aire" de 2019 del American Thoracic Society, Salt Lake se clasificó en el puesto 23 entre las ciudades estadounidenses con mayor impacto en la salud debido a la calidad del aire. Entre los más vulnerables están los ancianos y los niños.

For all of its breathtaking mountainous beauty, Salt Lake City comes with the tradeoff of periodic poor air. In the 2019 “Health of the Air” report by the American Thoracic Society, Salt Lake ranked 23rd among U.S. cities with the highest health impacts due to air quality. Among those most vulnerable are the elderly and children.

Huntsman Cancer Institute (HCI) has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Translational researchers extend basic discoveries made in the laboratory and apply them to solve clinical problems and benefit patients through new diagnostic and therapeutic approaches.

When construction is complete in 2021, Huntsman Cancer Institute will implement the latest advance in proton therapy, called intensity-modulated proton therapy. Proton therapy is the favored approach for many tumors in and around vital structures such as the spinal cord and brain stem. It is also the preferred treatment for certain childhood cancers. We are committed to bringing cutting-edge care to our patients, and proton therapy will be the next step in that promise.

New research published in Nature Communications from scientists at Huntsman Cancer Institute at the University of Utah, in collaboration with the Stanford University School of Medicine, shows a specific protein regulates both the initiation of cancer spreading and the self-renewal of cancer cells in medulloblastoma, a type of pediatric brain cancer.

Huntsman Cancer Institute began in 1995 with an empty lot and a dream full of promise. Twenty-two years later, HCI opened a major expansion that doubled its research capacity.

SALT LAKE CITY—More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer. Writing this week in the journal Cell Reports, researchers at Huntsman Cancer Institute (HCI) at the University of Utah report they have identified an existing group of drugs that appear to reduce or eliminate a certain subgroup of childhood brain cancers while sparing normal brain tissue. The research was conducted using a new zebrafish animal model system developed by the researchers, which closely resembles an aggressive subtype of pediatric brain tumors.